Ajanta Pharma Ltd Financial Statement - Ajanta Pharma Ltd Balance Sheet | Research 360 by Motilal Oswal
15:55 Apr 19

Ajanta Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2085.40
+6.55 (+0.32%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Ajanta Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2085.40
+6.55 (+0.32%)
15:55 Apr 19
Quality
image/svg+xml

71/100
High Financial Strength

Valuation
image/svg+xml

28/100
Expensive Valuation

Technical

49/100
Technically Neutral

Strength

7

Weakness

1

Opportunity

0

Threats

1

17.35 %

ROE %

12.56 %

ROA %

45.89

EPS

268.14

BVPS

15.71 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM 2023
Net Sales
2587.87 2889.69 3340.99 3742.64 4036.47
Operating Expenses +
1904.54 1891.13 2411.69 2959.39 3011.05
Raw Material
672.46 795.95 915.44 1024.64 1067.48
Increase Decrease in Cost
-16.75 -150.9 -83.17 25.76 -24.39
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
485.59 548.25 645.78 785.14 890.47
Miscellaneous Expenses
987.5 876.91 1205.84 1416.41 1077.49
Operating Profit
683.33 998.56 929.3 783.25 1025.42
Other Income
92.19 25.98 115.68 98.64 103.5
Depreciation
95.72 116.09 125.3 130.8 134.17
Interest
11.91 8.27 10.2 5.84 6.81
Profit before tax and exceptio..
667.89 900.18 909.48 745.25 987.94
Exceptional Items
-3.92 0 0 0 0
PBT
663.97 900.18 909.48 745.25 987.94
Provision for Taxation
196.27 246.31 196.8 157.27 252.24
Net Profit
467.7 653.87 712.68 587.98 735.7
NET Profit after MI
467.7 653.87 712.68 587.98 735.7
EPS
53.6 75.09 82.45 45.89 58.26
Operating Profit Margin (%)
26.41 34.56 27.82 20.93 25.4
Net Profit Margin (%)
18.07 22.63 21.33 15.71 18.23

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 66.20 66.20 66.20 66.20 66.10
FII 8.50 9.10 10.00 10.20 10.00
MF 14.80 13.90 12.80 13.10 13.80
Public 7.80 8.00 8.20 7.80 7.90
Others 2.70 2.80 2.80 2.70 2.20
Shareholder Shares Holding %

Download Our App On: